DEF 14A
Teva Pharmaceuticals on Twitter: "Dr. Michael Hayden, head of Teva's global R&D, meets with #HuntingtonsDisease patients and their families at the Vatican. #Hddennomore. https://t.co/LeojD4GEDe" / Twitter
The Difficulties of Cloning a CEO - Bloomberg
How One of the World's Leading Geneticists Recovered His Family's Stolen Legacy - Tablet Magazine
VIP Reception
Michael Hayden - News, Articles, Whitepapers - Drug Target Review
Michael Hayden, MD, PhD - World Neuroscience Innovation Forum
ABOUT US | Prilenia Therapeutics
Help 4 HD HIPE Virtual Talks to Dr. Michael Hayden~Prilenia.mp4 on Vimeo
New Teva CEO shakes up structure and leadership at troubled drugmaker | The Times of Israel
Teva CEO promises to reshape, refocus company | Reuters
New Teva CEO shakes up structure and executive ranks as major layoffs loom | Fierce Pharma
Michael R. Hayden - Wikipedia
Michael Hayden - Principal @ Chertoff Group - Recent News and Activity
Michael Hayden - News, Articles, Whitepapers - Drug Target Review
Michael Hayden - Director at n-Lorem Foundation | The Org
Teva to Cut Up to 25% of Israel Workforce, Calcalist Says - Bloomberg
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with
Teva In Transition: Generics, Specialty And 'The Space Between' :: Scrip
Dr. Michael Hayden MBChB , PhD - Chief Executive Officer - Prilenia | LinkedIn
Teva shares surge on corporate shake-up - MarketWatch
